why choose us

First received: December 06, 2022

Clinical Trial: Large De-NOVo Coronary artEry Disease Treated With Sirolimus Drug Eluting Balloon (LOVE DEB)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Coronary Artery Disease

Study Type: OBSERVATIONAL


Official Title: Large De-NOVo Coronary artEry Disease Treated With Sirolimus Drug Eluting Balloon: Prospective Evaluation of Safety & Efficacy of SELUTION SLR TM Drug Eluting Balloon (LOVE-DEB Registry)

Brief Summary: The objective of this post-market Registry is to evaluate the safety and efficacy of SELUTION SLR, a Sirolimus Drug Eluting Balloon (DEB), in treating de novo native coronary artery disease in larger vessels (? 2.75 mm).This is a post-market registry that collects the data of patients who have been treated with a SELUTION DEB.The primary objective is to evaluate the proportion of subjects who underwent Target Lesion Revascularization (TLR) within 1 year of the baseline PCI.

Read more